Increased levels of (2'-5')oligo(A) polymerase activity in human lymphoblastoid cells treated with glucocorticoids.
about
Structure of two forms of the interferon-induced (2'-5') oligo A synthetase of human cells based on cDNAs and gene sequencesMolecular cloning and sequence of partial cDNA for interferon-induced (2'-5')oligo(A) synthetase mRNA from human cellsMonoclonal antibodies to 5'-triphospho-(2'-5')adenyladenosine oligonucleotides(2'-5') oligo adenylate synthetase activity in leucocytes of patients with inflammatory bowel disease.RNase L attenuates mitogen-stimulated gene expression via transcriptional and post-transcriptional mechanisms to limit the proliferative responseImmunological evidence for the in vivo occurrence of (2'-5')adenylyladenosine oligonucleotides in eukaryotes and prokaryotesPathologic effects of RNase-L dysregulation in immunity and proliferative control.5'-O-Monophosphoryladenylyl(2' goes to 5')adenylyl(2' goes to 5')adenosine is an antagonist of the action of 5'-O-triphosphoryladenylyl-(2' goes to 5')adenylyl(2' goes to 5')adenosine and double-stranded RNA.Core (2'-5')oligoadenylate and the cordycepin analog: inhibitors of Epstein--Barr virus-induced transformation of human lymphocytes in the absence of interferon.Modulation of ppp(A2'p)nA-dependent RNase by a temperature-sensitive mutant of vaccinia virusAccumulation of 2',5'-oligoadenylates in encephalomyocarditis virus-infected mice.Growth regulation of melanoma cells by interferon and (2'-5')oligoadenylate synthetaseElevated levels of (2'-5')oligoadenylic acid polymerase activity in growth-arrested human lymphoblastoid Namalva cellsInduction and maintenance of 2',5'-oligoadenylate synthetase in interferon-treated chicken embryo cells.(2'-5')Oligoadenylate in rat liver: modulation after partial hepatectomyRegulation of cell proliferation and differentiation by interferons.Ribonucleotide metabolism--fresh approaches to viral and cancer chemotherapy.Recessive genetic deregulation abrogates c-myc suppression by interferon and is implicated in oncogenesis.Interferon-mediated changes in the expression of CYP1A1 in human B lymphoblastoid (AHH-1 TK +/-) cells.Interferon-specific effects on protein synthesis in P3HR-1 cells.Methylxanthine treatment of rats reduces 2,5-oligoadenylate synthesis in liver nuclei.
P2860
Q24555798-F6C4C10F-2E68-446F-8AE4-D6FFABEF42E7Q24594890-FAD42DE6-3439-4237-8607-585F8B375975Q28365877-0E9E9421-9099-4A21-B2CD-14D2EA1B43B3Q34526965-847E7541-9465-473E-9722-9D6F5C2BB117Q34580412-C7DF8287-D969-44BD-B25E-B82EE796B7D5Q36256951-A4BED10C-7FCF-44CC-9E80-13D63A6CBA85Q36310770-0A280769-1719-4477-BE62-9BAC57EB58C4Q36373135-46276A39-2F91-4C95-8146-F9C6F51ED50BQ36377385-9618033B-DDE7-4FCD-902D-0351B6DC10C5Q36781028-D8F7E013-6AF4-432D-930C-B09C9D529D21Q36887708-016E1FE1-B96D-4268-9A77-CF49B37651BDQ36938686-6BA71600-445A-488B-989D-25EDA7ED7715Q36957913-E7260E20-9E58-4F8F-9419-CA0CBE80BFF3Q36976317-8F0E1D6D-6295-445D-8BF0-9235092B2F8BQ37343903-879BFFE6-7139-4A12-A649-44FB791E9D86Q38393349-ADDE21BC-595A-4F2C-9AD9-2A47A5C90C3CQ38694346-8B6475DB-F148-47A4-B2A9-E54FEAE9B429Q40650315-E66FC956-81E3-49DE-99F0-DFA0FCF930B2Q41261667-FCFB3235-A9B8-4CBE-8567-81CA14AC4617Q41320217-B262F5DA-EFA4-4306-AEA4-31ECB92B723AQ42522423-7F33B00A-9F65-4624-946B-84308AC2EFD3
P2860
Increased levels of (2'-5')oligo(A) polymerase activity in human lymphoblastoid cells treated with glucocorticoids.
description
1980 nî lūn-bûn
@nan
1980年の論文
@ja
1980年学术文章
@wuu
1980年学术文章
@zh-cn
1980年学术文章
@zh-hans
1980年学术文章
@zh-my
1980年学术文章
@zh-sg
1980年學術文章
@yue
1980年學術文章
@zh
1980年學術文章
@zh-hant
name
Increased levels of (2'-5')oli ...... treated with glucocorticoids.
@ast
Increased levels of (2'-5')oli ...... treated with glucocorticoids.
@en
type
label
Increased levels of (2'-5')oli ...... treated with glucocorticoids.
@ast
Increased levels of (2'-5')oli ...... treated with glucocorticoids.
@en
prefLabel
Increased levels of (2'-5')oli ...... treated with glucocorticoids.
@ast
Increased levels of (2'-5')oli ...... treated with glucocorticoids.
@en
P2860
P356
P1476
Increased levels of (2'-5')oli ...... treated with glucocorticoids.
@en
P2093
C Baglioni
I Krishnan
P2860
P304
P356
10.1073/PNAS.77.11.6506
P407
P577
1980-11-01T00:00:00Z